NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

No I did not. My statement is very simple.

. Comparison trial randomizes after chemo-radiation is complete (about 3+ months after surgery) and counts survival from randomization.

. NWBO P3 trial randomized after chemo-radiation is complete (about 3+ months after surgery) and counts survival from surgery.

If NWBO was to count months from ranodomation, like every other trial on his chart, the OS would be 3+ months less.

ATL argues that this is proper. NWBO should gain 3+ months OS only because they call the start time different.

Why not back up start time to diagnosis? Or first symptom? They could get 6+ months OS benefit easily in the exact same actual results.